Presepsin in the diagnosis of sepsis
- 7 October 2023
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 550, 117588
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Diagnostic and prognostic value of sCD14-ST—presepsin for patients admitted to hospital intensive care unit (ICU)Wiener klinische Wochenschrift, 2015
- Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean populationJournal of Critical Care, 2014
- Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injuryBMC Anesthesiology, 2014
- Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatmentCritical Care, 2014
- Evaluation of soluble CD14 subtype (presepsin) in burn sepsisBurns, 2014
- Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary studyClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency departmentCritical Care, 2013
- Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective studyCritical Care, 2013
- Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsisClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndromeJournal of Infection and Chemotherapy, 2011